Metastatic Breast Cancer
Latest News
Radiologist fatigue affects breast imaging interpretation
The impact of time and experience on overall patient recall and false-positive rates has not been well-studied.
News
The evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapies
“The fact that we’re now talking about fourth- and fifth-line therapies for HER2-positive MBC represents a major advance in the management of...
Latest News
Liquid biopsy in metastatic breast cancer management: Where does it stand in clinical practice?
Liquid biopsies — blood analyses that allow oncologists to detect circulating tumor cells and circulating tumor DNA in the blood — are...
Latest News
Biomarker testing in metastatic breast cancer management: ‘Essential’
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
Latest News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
News
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
News
Better survival with extended letrozole in early-stage breast cancer
Guidelines for duration of endocrine therapy ‘should be updated.’
News
Twelve-month overall survival benefit with ribociclib for metastatic breast cancer
It’s the first phase 3 trial to report a median overall survival beyond 5 years in advanced breast cancer.
News
Polygenic breast cancer risk scores strive to overcome racial bias
Efforts...
News
Real-world survival inferior to clinical trials for certain metastatic breast cancer treatments